Selecxine

  • Biotech or pharma, therapeutic R&D
Selecxine is a bio start-up specialized in the field of immunotherapeutics to develop novel antibodies to cure various life-threatening diseases. Our lead asset, SLC-3010, is an IL-2 antibody conjugate.

Address

Seoul
South Korea

Website

http://www.selecxine.com

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS